Business Context and Reporting Period
This Form 8-K was filed by 22nd Century Group, Inc. on July 23, 2013, reporting events that occurred on July 23 and July 24, 2013. The filing primarily addresses the conversion of outstanding Series B Warrants into common stock.
Key Financial Metrics
- Gross Proceeds: $1.25 million generated from the warrant conversion.
- Shares Issued: 2,083,334 shares of common stock.
- Conversion Price: $0.60 per share.
- Outstanding Warrants: Zero Series B Warrants remain outstanding following this transaction.
- Other Metrics: The filing text does not provide clear values for revenue, profit, operating cash flow, margins, total debt, or liquidity ratios.
Material Changes
The material change reported is the full conversion of all remaining Series B Warrants held by Sabby Healthcare Volatility Master Fund, Ltd. and Sabby Volatility Warrant Master Fund Ltd. This transaction eliminated the warrant liability and increased the company's common share count by approximately 2.08 million shares.
Guidance, Outlook, and Risks
The filing includes a Regulation FD disclosure referencing a press release issued on July 24, 2013, regarding the conversion. The document does not contain forward-looking guidance, management commentary on future operations, specific risk factors, or details on contingencies beyond the completion of the warrant conversion.
Investor Verification Checklist
- Verify the updated total share count and potential dilution impact on existing shareholders.
- Confirm the cash balance increase of $1.25 million in the company's most recent balance sheet.
- Review the attached press release (Exhibit 99.1) for any additional context on the relationship with the warrant holders.
- Check subsequent filings for any remaining unregistered equity sales or modifications to security holder rights.